Scan to Download
One power score. Smarter investment decisions
Connect Biopharma Holdings Ltd
CNTB1.570USD
-0.040-2.48%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
87.26MMarket Cap
LossP/E TTM
Connect Biopharma Holdings Ltd
1.570
-0.040-2.48%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q1
FY2024H1
FY2023H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---12.59M
-1585.11%-9.96M
---591.00K
74.41%-7.97M
---31.16M
Net income from continuing operations
---12.90M
-18.16%-10.27M
---8.69M
125.35%7.71M
---30.41M
Operating gains losses
--171.00K
5.49%173.00K
--164.00K
-6.11%476.00K
--507.00K
Other non-cash items
---288.00K
-179.78%-249.00K
---89.00K
96.19%-17.00K
---446.00K
Change in working capital
---526.00K
-108.75%-587.00K
--6.71M
-833.77%-17.89M
---1.92M
-Change in receivables
--8.00K
--781.00K
--0.00
-900.93%-3.21M
---321.00K
-Change in prepaid expenses
---2.24M
-206.53%-1.29M
--1.21M
----
----
-Change in payables and accrued expense
----
----
----
390.15%589.00K
---203.00K
-Change in other current assets
--2.00K
-800.00%-9.00K
---1.00K
104.74%23.00K
---485.00K
-Change in other current liabilities
---505.00K
-100.08%-5.00K
--6.62M
-2620.61%-13.33M
---490.00K
Cash from non-recurring investing activities
Cash from operating activities
---12.59M
-1585.11%-9.96M
---591.00K
74.41%-7.97M
---31.16M
Investing cash flow
Net cash from continuing investing activities
--303.00K
--79.00K
--0.00
50.87%436.00K
--289.00K
Capital expenditures
--303.00K
--81.00K
--0.00
50.87%436.00K
--289.00K
Net cash flow from disposal of fixed assets
--303.00K
--79.00K
--0.00
50.87%436.00K
--289.00K
Net cash flow from investment products
--5.43M
-322.29%-20.56M
--9.25M
-62.93%12.76M
--34.41M
Net cash flow from other investing activities
----
----
----
-25.71%-44.00K
---35.00K
Cash from non-current investing activities
Net cash flow from investing activities
--5.13M
-323.15%-20.64M
--9.25M
-63.98%12.28M
--34.09M
Financing cash flow
Cash flow from continuous financing activities
--161.00K
--2.00K
--0.00
62.30%-46.00K
---122.00K
Net cash flow from debt Issuance/repayment
----
----
----
-2.78%-148.00K
---144.00K
Net cash flow from common stock issuance/repurchase
--143.00K
----
----
-9.09%20.00K
--22.00K
Proceeds from stock option exercised by employees
--18.00K
--2.00K
--0.00
--82.00K
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
--161.00K
--2.00K
--0.00
62.30%-46.00K
---122.00K
Net cash flow
Beginning cash balance
--47.71M
-25.96%78.23M
--105.66M
34.17%106.01M
--79.01M
Current period cash flow changes
---7.08M
-461.73%-30.52M
--8.44M
60.33%4.17M
--2.60M
Effect of exchange rate changes
--224.00K
133.94%75.00K
---221.00K
57.55%-90.00K
---212.00K
Ending cash balance
--40.63M
-58.19%47.71M
--114.10M
35.00%110.17M
--81.61M
Free cash flow
---12.89M
-1598.82%-10.04M
---591.00K
73.25%-8.41M
---31.44M
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
